Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» non-small cell lung cancer
non-small cell lung cancer
FDA staff questions Clovis drug's benefit over current treatments
Yahoo/Reuters
Fri, 04/8/16 - 11:08 am
FDA
Clovis Oncology
rociletinib
non-small cell lung cancer
What Latest Xalkori Approval Means for Pfizer
Bidness, ETC
Mon, 03/14/16 - 10:05 am
Pfizer
Xalkori
FDA
non-small cell lung cancer
Keytruda: Merck’s New Blockbuster for Its Immuno-Oncology Franchise
Yahoo/Market Realist
Sun, 03/6/16 - 11:33 am
Keytruda
Merck
immuno-oncology
melanoma
non-small cell lung cancer
Lilly's lung cancer drug Portrazza wins EU approval as first-line biologic
BioPharma Dive
Fri, 02/26/16 - 09:34 am
Eli Lilly
Portrazza
Europe
biologics
non-small cell lung cancer
Clovis Oncology Issues Update On Rociletinib, Will Meet With FDA On April 12
Yahoo/Benzinga
Fri, 02/12/16 - 04:25 pm
Clovis Oncology
rociletinib
FDA
non-small cell lung cancer
This Lung Cancer Drug May Not Be What It Seems, Chemists Say
Forbes
Fri, 01/1/16 - 11:50 am
non-small cell lung cancer
antroquinonol
Taiwan
Golden Biotechnology Corporation
Boehringer grabs 'breakthrough,' plots pivotal trials for rival to AstraZeneca, Clovis
Fierce Biotech
Mon, 12/21/15 - 10:50 am
Boehringer Ingelheim
breakthrough therapies
BI1482694
AstraZeneca
Clovis Oncology
non-small cell lung cancer
Lilly's price for Portrazza way too high for its limited benefit in lung cancer, doctors say
Fierce Pharma
Mon, 12/14/15 - 04:15 pm
drug pricing
Portrazza
Eli Lilly
non-small cell lung cancer
It's official: FDA shoots past 2014's new drugs record with Roche lung cancer med nod
BioPharma Dive
Mon, 12/14/15 - 11:03 am
FDA
Roche
Genentech
non-small cell lung cancer
Alecensa
drug approvals
Pfizer Announces U.S. FDA Acceptance and Priority Review of Supplemental New Drug Application for XALKORI® (crizotinib) for the Treatment of Patients with ROS1-Positive Metastatic Non-Small Cell Lung Cancer
Yahoo
Tue, 12/8/15 - 11:24 am
Pfizer
FDA
Xalkori
non-small cell lung cancer
Clovis Oncology's Loss Could Be a Win for AstraZeneca
Motley Fool
Thu, 11/19/15 - 09:47 am
Clovis Oncology
AstraZeneca
rociletinib
Tagrisso
non-small cell lung cancer
In major victory, AstraZeneca wins FDA approval for potential $3B lung cancer med
BioPharma Dive
Mon, 11/16/15 - 11:54 am
AstraZeneca
FDA
Tagrisso
non-small cell lung cancer
Clovis Oncology Gets Hit Hard: FDA Delays Approval
Bidness, ETC
Mon, 11/16/15 - 09:18 am
Clovis Oncology
FDA
rociletinib
non-small cell lung cancer
Merck's Keytruda has a shot at a bigger share of NSCLC sales
Fierce Pharma Marketing
Wed, 10/28/15 - 02:59 pm
Merck
Keytruda
non-small cell lung cancer
Opdivo
Bristol-Myers Squibb
UBS analysts weigh in on FDA’s expanded approval of Merck’s Keytruda for the treatment of lung cancer
Bidness, ETC
Wed, 10/7/15 - 10:05 am
Merck
non-small cell lung cancer
FDA
Keytruda
Merck's Keytruda snags FDA approval for NSCLC, but label is narrow
Fierce Pharma
Fri, 10/2/15 - 04:57 pm
Merck
Keytruda
FDA
non-small cell lung cancer
Clovis Oncology Inc Giving AstraZeneca plc A Hard Time In Cancer
Bidness, ETC
Fri, 10/2/15 - 09:11 am
Clovis Oncology
AstraZeneca
rociletinib
AZD9291
non-small cell lung cancer
Don't be quick to peg Merck's Keytruda in second place for NSCLC, analyst says
Fierce Pharma Marketing
Mon, 09/28/15 - 10:15 am
Merck
Keytruda
non-small cell lung cancer
Bristol-Myers Squibb
Opdivo
Amgen And Allergan Announce Positive Top-line Results From Phase 3 Study of Biosimilar Candidate ABP 215
Yahoo
Wed, 09/23/15 - 09:56 am
Amgen
Allergan
ABP 215
non-small cell lung cancer
Clovis leaps as AstraZeneca's AZD9291 disappoints on lung cancer
Fierce Biotech
Thu, 09/10/15 - 05:54 pm
Clovis Oncology
AstraZeneca
AZD9291
non-small cell lung cancer
Pages
« first
‹ previous
…
11
12
13
14
15
16
17
18
19
…
next ›
last »